Document ID: chunk:federal_register_of_legislation:F2024C00988:reg:104
Version: federal_register_of_legislation:F2024C00988
Segment Type: reg
Provision Reference: reg 104
Character Range: 169789–171015

104  Transitional provision relating to the National Health (Pharmaceutical Benefits) Amendment (2024 Measures No. 1) Regulations 2024
 (1) This section applies in relation to prescriptions for the supply of pharmaceutical benefits written before 1 July 2024.
 (2) Despite the repeal and substitution of section 30 by the National Health (Pharmaceutical Benefits) Amendment (2024 Measures No. 1) Regulations 2024:
 (a) a practitioner may submit a prescription to the Minister in accordance with subsection 30(3) as in force immediately before 1 April 2024; and
 (b) the Minister may make a variation under subsection 30(1) as in force immediately before 1 April 2024 in relation to the practitioner; and
 (c) the prescription is taken to have been written in accordance with an authorisation under section 30 if the prescription is authorised in accordance with subsection 30(4) as in force immediately before 1 April 2024.
 (3) If the Minister makes a variation in accordance with paragraph 30(4)(a), (b) or (c) as in force immediately before 1 April 2024, the practitioner is not required to comply with the following provisions in relation to the authorised prescription:
 (a) paragraph 40(1)(i);
 (b) paragraph 41(3)(a).